Intellectual Property India Publishes Patent Application for Pharmaceutical Formulations Of Antibodies That Bind Interleukin 13

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617084004 A) filed by Apogee Therapeutics, Inc. on July 08, 2026, for Pharmaceutical Formulations Of Antibodies That Bind Interleukin 13.

Inventors include Prentice, Holly; Ratnaswamy, Gayathri; Dabora, Rebecca Lucille; and Noyes, Aaron.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: Described herein are pharmaceutical formulations of interleukin (IL)- 13 antibodies. Also provided are pharmaceutical formulations for use in the treatment of an inflammatory disorder or disease.

Disclaimer: Curated by HT Syndication.